These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2404064)

  • 41. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
    J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.
    Lee JM; Watts TH
    J Immunol; 1990 Nov; 145(10):3360-6. PubMed ID: 2230121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
    Soos JM; Johnson HM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
    Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
    Mourad W; Scholl P; Diaz A; Geha R; Chatila T
    J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
    Spertini F; Spits H; Geha RS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
    Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
    Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
    Rich RR; Mollick JA; Cook RG
    Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gamma delta T cell reactivity towards bacterial superantigens.
    Rust CJ; Koning F
    Semin Immunol; 1993 Feb; 5(1):41-6. PubMed ID: 8467094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
    Wahlsten JL; Mills CD; Ramakrishnan S
    J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
    Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
    J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.
    Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP
    J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
    Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
    J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases.
    Morio T; Geha RS; Chatila TA
    Eur J Immunol; 1994 Mar; 24(3):651-8. PubMed ID: 7510238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.